CAPECITABINE , CALCIUM FOLINATE , FLUOROURACIL , DURVALUMAB , OXALIPLATIN clinical trials

Phase II study of Durvalumab (MEDI4736) plus Total Neoadjuvant Therapy (TNT) in locally advanced rectal cancer (The DUREC trial)

This study is looking at a new way to treat locally advanced rectal cancer. It combines standard chemotherapy and radiotherapy with a new drug called Durvalumab to see if this combination causes the cancer to completely disappear before surgery.